Simple Summary Osteosarcoma is a malignant bone cancer with little progress in treatment and outcomes for the past 30 years. In this study, we attempted to subtype 102 tumor samples into distinct subtypes based on their gene expression and to explore specific expression profiles that would allow for precise treatment of each subtype. We identified three tumor subtypes with different functional characteristics. One identified subtype was shown to be more resistant to standard chemotherapy drugs and was linked to poorer patient outcomes. We also found that a natural compound, hesperidin, could increase the effectiveness of a typical chemotherapeutic doxorubicin in vitro. These findings could be used to guide more tailored treatment strategies in the early-stages of this disease, ultimately improving the quality of life of these young patients.
Exploratory Analysis of Molecular Subtypes in Early-Stage Osteosarcoma: Identifying Resistance and Optimizing Therapy
Luka Bojic,Mina Perić,J. Karanović,Emilija Milošević,Natasa Kovacevic Grujicic,M. Milivojevic
Published 2025 in Cancers
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Cancers
- Publication date
2025-05-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-1 of 1 citing papers · Page 1 of 1